Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Vaccaro · SciRah

Researcher profile · Semantic Scholar

G. Vaccaro

Share profile

G. Vaccaro — researcher profile on SciRah

h-index: 25
Works: 59
Citations: 3,599

Most-cited papers

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
G. Abou-Alfa, V. Sahai, A. Hollebecque, G. Vaccaro +15 more
2020The Lancet Oncology1,309 citations Open access
Semantic Scholar
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.
M. Katz, Q. Shi, J. Meyers, J. Herman +14 more
2022JAMA Oncology296 citations Open access
Semantic Scholar
Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions
L. Zarour, Sudarshan Anand, K. Billingsley, W. Bisson +14 more
2017Cellular and Molecular Gastroenterology and Hepatology255 citations Open access
Semantic Scholar
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100
Markus Moehler, M. Dvorkin, N. Boku, M. Özgüroğlu +17 more
2020Journal of Clinical Oncology196 citations Open access
Semantic Scholar
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
G. Abou-Alfa, S. Qin, B. Ryoo, S.-N. Lu +23 more
2018Annals of Oncology196 citations Open access
Semantic Scholar
Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.
M. Katz, Q. Shi, J. Meyers, J. Herman +14 more
2021119 citations
Semantic Scholar
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Tomoko Yamazaki, A. Gunderson, M. Gilchrist, M. Whiteford +29 more
2022The Lancet Oncology114 citations
Semantic Scholar
Nivolumab (NIVO) + ipilimumab (IPI) + cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
T. Yau, V. Zagonel, A. Santoro, M. Acosta-Rivera +15 more
2020100 citations
Semantic Scholar
MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease.
L. Manfré, E. Giarratano, A. Maggio, A. Banco +2 more
1999AJR. American journal of roentgenology90 citations
Semantic Scholar
Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer
J. I. Young, S. Mongoué-Tchokoté, Nicole Wieghard, M. Mori +3 more
2016Diseases of the Colon & Rectum82 citations
Semantic Scholar
Phase 2 Study of MK-2206, an Allosteric Inhibitor of AKT, as Second-Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer: A SWOG Cooperative Group Trial (S1005)
R. K. Ramanathan, Shannon L. McDonough, H. Kennecke, S. Iqbal +6 more
2015Cancer78 citations Open access
Semantic Scholar
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
D. B. Hewitt, Nicholas N. Nissen, H. Hatoum, B. Musher +17 more
2020Annals of Surgery73 citations
Semantic Scholar
FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)
A. Vogel, V. Sahai, A. Hollebecque, G. Vaccaro +14 more
2019Annals of Oncology72 citations Open access
Semantic Scholar
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
T. Yau, V. Zagonel, A. Santoro, M. Acosta-Rivera +15 more
2022Journal of Clinical Oncology62 citations Open access
Semantic Scholar
Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer.
Kelly R. Haisley, A. Laird, N. Nabavizadeh, K. Gatter +6 more
2016JAMA Surgery53 citations
Semantic Scholar
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia
J. Weinberg, A. Volkheimer, Youwei Chen, Bethany E. Beasley +12 more
2007American journal of hematology/oncology53 citations
Semantic Scholar
Results of the JAVELIN Gastric 100 phase 3 trial: avelumab maintenance following first-line (1L) chemotherapy (CTx) vs continuation of CTx for HER2− advanced gastric or gastroesophageal junction cancer (GC/GEJC).
M. Moehler, M. Dvorkin, M. Ozguroglu, M. Ryu +16 more
202047 citations
Semantic Scholar
Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Kelly R. Haisley, Kyle D. Hart, N. Nabavizadeh, K. Bensch +5 more
2017Diseases of the esophagus43 citations
Semantic Scholar
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios can Predict Treatment Response to Neoadjuvant Therapy in Esophageal Cancer
Patrick J. McLaren, Nathan W. Bronson, Kyle D. Hart, G. Vaccaro +4 more
2017Journal of Gastrointestinal Surgery37 citations
Semantic Scholar
Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy.
J. P. Dolan, Taranjeet Kaur, B. Diggs, R. A. Luna +10 more
2016Diseases of the esophagus37 citations Open access
Semantic Scholar
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC).
G. Abou-Alfa, S. Qin, B. Ryoo, Sheng-Nan Lu +16 more
201634 citations
Semantic Scholar
Patients With Hepatocellular Carcinoma Near the End of Life: A Longitudinal Qualitative Study of Their Illness Experiences
Lissi Hansen, S. Rosenkranz, G. Vaccaro, Michael F. Chang
2015Cancer Nursing34 citations Open access
Semantic Scholar
Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
N. Nabavizadeh, R. Shukla, D. Elliott, T. Mitin +7 more
2016Diseases of the esophagus28 citations
Semantic Scholar
Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations.
A. Hollebecque, M. Borad, V. Sahai, D. Catenacci +8 more
2018Annals of Oncology27 citations Open access
Semantic Scholar
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.
M. Moehler, M. Ryu, M. Dvorkin, Keun-Wook Lee +18 more
2019Future Oncology25 citations Open access
Semantic Scholar
Pemigatinib for previously treated locally advanced/metastatic cholangiocarcinoma (CCA): Update of FIGHT-202.
G. Abou-Alfa, V. Sahai, A. Hollebecque, G. Vaccaro +14 more
2021Journal of Clinical Oncology20 citations
Semantic Scholar
Small Bowel Adenocarcinoma
Emerson Y. Chen, G. Vaccaro
2018Clinics in Colon and Rectal Surgery19 citations Open access
Semantic Scholar
Effect of Time to Surgery of Colorectal Liver Metastases on Survival
Emerson Y. Chen, S. Mayo, T. Sutton, Matthew R. Kearney +4 more
2020Journal of Gastrointestinal Cancer17 citations Open access
Semantic Scholar
Specific Gene Expression Profiles are Associated with a Pathologic Complete Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Patrick J. McLaren, A. Barnes, W. Terrell, G. Vaccaro +3 more
2017American Journal of Surgery13 citations Open access
Semantic Scholar
Safety and Outcomes Following Resection of Colorectal Liver Metastases in the Era of Current Perioperative Chemotherapy
Ilia Gur, B. Diggs, J. Wagner, G. Vaccaro +4 more
2013Journal of Gastrointestinal Surgery13 citations Open access
Semantic Scholar
JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).
M. Moehler, M. Ryu, Keun-Wook Lee, H. Coşkun +15 more
201811 citations
Semantic Scholar
Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
M. Sinha, Courtney B. Betts, Li Zhang, M. Griffith +25 more
2023Journal for ImmunoTherapy of Cancer10 citations Open access
Semantic Scholar
Updated results of a phase 1 study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC; SGNS40-001).
A. Coveler, M. Gutierrez, G. Vaccaro, U. Brown-Glaberman +9 more
2023Journal of Clinical Oncology7 citations Open access
Semantic Scholar
Lymph Node Harvest During Esophagectomy Is Not Influenced by Use of Neoadjuvant Therapy or Clinical Disease Stage
R. A. Luna, J. P. Dolan, B. Diggs, Nathan W. Bronson +8 more
2015Journal of Gastrointestinal Surgery7 citations
Semantic Scholar
Phase I study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
A. Coveler, D. Bajor, A. Masood, E. Yilmaz +9 more
20206 citations
Semantic Scholar
A phase II study of MK-2206, an allosteric inhibitor of AKT as second-line therapy for advanced gastric and gastroesophageal junction (GEJ) cancer: A SWOG Cooperative Group trial (S1005).
R. Ramanathan, Shannon L. McDonough, H. Kennecke, S. Iqbal +6 more
20146 citations
Semantic Scholar
Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma
Emerson Y. Chen, Adel Kardosh, N. Nabavizadeh, B. Foster +12 more
2023Cancer Medicine5 citations Open access
Semantic Scholar
SO-4 Progression-free survival in patients with cholangiocarcinoma with FGFR2 fusions or rearrangements: A FIGHT-202 post-hoc analysis of prior systemic therapy response
G. Abou-Alfa, V. Sahai, A. Hollebecque, G. Vaccaro +15 more
2021Annals of Oncology5 citations Open access
Semantic Scholar
Immune modulatory effects of ibrutinib in pancreatic ductal adenocarcinoma.
M. Sinha, M. Griffith, Courtney B. Betts, G. Choe +10 more
2019Annals of Oncology4 citations Open access
Semantic Scholar
Preliminary results of a phase I study of external beam radiation therapy (EBRT), oxaliplatin (OX), bevacizumab (BV), and capecitabine (CAP) for locally advanced or metastatic adenocarcinoma of the rectum
B. Czito, J. Bendell, C. Willett, G. Vaccaro +5 more
20064 citations
Semantic Scholar
Chemoradiation for Locally Advanced Unresectable Pancreatic Cancer-What Now?
G. Vaccaro, C. Lopez
2017JAMA Oncology3 citations
Semantic Scholar
A Phase II Trial of TGFβ Type I Receptor Inhibitor, Galunisertib, plus Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
T. Yamazaki, A. Gunderson, M. Gilchrist, M. Whiteford +28 more
2022International Journal of Radiation Oncology, Biology, Physics2 citations
Semantic Scholar
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
Matthew R. Kearney, Emerson Y. Chen, G. Vaccaro, J. Strother +5 more
2019Anticancer Research2 citations Open access
Semantic Scholar
Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC)
J. Waller, W. Naugler, Atif Zaman, S. Orloff +6 more
20132 citations
Semantic Scholar
Use of circulating cancer cell hybrids to monitor treatment response to hepatic arterial infusion in patients with colorectal cancer metastatic to the liver
L. Zarour, John R. Swain, K. Billingsley, C. Lopez +4 more
2018HPB1 citations Open access
Semantic Scholar
Updates in the systemic treatment of hepatocellular carcinoma
Emerson Y. Chen, C. Lopez, G. Vaccaro
20181 citations Open access
Semantic Scholar
Living with hepatocellular carcinoma from the patient perspective: A longitudinal study.
Lissi Hansen, G. Vaccaro, S. Rosenkranz
20141 citations
Semantic Scholar
Phase I study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (PDAC) (trial in progress).
D. Bajor, M. Gutierrez, G. Vaccaro, A. Masood +9 more
20210 citations
Semantic Scholar
Phase II study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
Emerson Y. Chen, G. Tormoen, Adel Kardosh, N. Nabavizadeh +13 more
20200 citations
Semantic Scholar
Effect of time to resection of colorectal liver metastases on recurrence risk.
Emerson Y. Chen, S. Mayo, K. Billingsley, G. Vaccaro +2 more
20180 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Lopez×12
Invite
C. Lopez — researcher profile on SciRah
K. Billingsley×8
Invite
K. Billingsley — researcher profile on SciRah
G. Abou-Alfa×7
Invite
G. Abou-Alfa — researcher profile on SciRah
J. P. Dolan×7
Invite
J. P. Dolan — researcher profile on SciRah

Emerson Y. Chen

×7

Invite

Emerson Y. Chen — researcher profile on SciRah

Invite

S. Mayo — researcher profile on SciRah

N. Nabavizadeh×6

Invite

N. Nabavizadeh — researcher profile on SciRah

Invite

V. Sahai — researcher profile on SciRah

A. Hollebecque×5

Invite

A. Hollebecque — researcher profile on SciRah

R. Al-Rajabi×5

Invite

R. Al-Rajabi — researcher profile on SciRah

Invite

A. Paulson — researcher profile on SciRah

Invite

M. Borad — researcher profile on SciRah